Skip to main content
logo
Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.90
-0.03 (-0.34%)
At close: May 19, 2026, 4:00 PM EDT
8.95
+0.05 (0.56%)
After-hours: May 19, 2026, 7:31 PM EDT

Novavax Market Cap

Novavax has a market cap or net worth of $1.46 billion as of May 19, 2026. Its market cap has increased by 41.95% in one year.

Market Cap
1.46B
Enterprise Value
968.23M
1-Year Change
41.95%
Ranking
#2293
Category
Small-Cap
Stock Price
$8.90

Market Cap Chart

Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.46B, an increase of 5,594.55%. That is a compound annual growth rate of 15.85%.

History

DateMarket Cap% Change
May 18, 20261.47B34.47%
Dec 31, 20251.09B-15.21%
Dec 31, 20241.29B125.87%
Dec 29, 2023570.20M-29.34%
Dec 30, 2022807.00M-92.54%
Dec 31, 202110.82B52.38%
Dec 31, 20207.10B6,609.55%
Dec 31, 2019105.80M-84.98%
Dec 31, 2018704.40M81.13%
Dec 29, 2017388.90M13.78%
Dec 30, 2016341.80M-84.90%
Dec 31, 20152.26B60.10%
Dec 31, 20141.41B32.47%
Dec 31, 20131.07B281.83%
Dec 31, 2012279.60M92.96%
Dec 30, 2011144.90M-46.33%
Dec 31, 2010270.00M8.56%
Dec 31, 2009248.70M90.28%
Dec 31, 2008130.70M-36.71%
Dec 31, 2007206.50M-18.35%
Dec 29, 2006252.90M33.74%
Dec 30, 2005189.10M46.70%
Dec 31, 2004128.90M-28.82%
Dec 31, 2003181.10M182.53%
Dec 31, 200264.10M-80.46%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Iovance Biotherapeutics1.51B
Ardelyx1.51B
Palvella Therapeutics1.51B
Damora Therapeutics1.50B
GH Research1.49B
Vir Biotechnology1.48B
MBX Biosciences1.47B
Nuvation Bio1.47B
Market Cap Rankings